Clinical features of hereditary resistance to 1,25-dihydroxyvitamin D (hereditary hypocalcemic vitamin D resistant rickets type II).
D015650:24,25-Dihydroxyvitamin D 3; D000284:Administration, Oral; D000367:Age Factors; D000505:Alopecia / Q000150:complications; D001842:Bone and Bones / Q000378:metabolism; D002117:Calcitriol / Q000502:physiology; D002118:Calcium / Q000097:blood; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use; D004872:Ergocalciferols / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007015:Hypophosphatemia, Familial / Q000145:classification / Q000235:genetics / Q000503:physiopathology*; D008297:Male; D008903:Minerals / Q000378:metabolism; D010375:Pedigree; D010758:Phosphorus / Q000097:blood; D014071:Tooth Abnormalities / Q000150:complications
D004100:Dihydroxycholecalciferols; D004872:Ergocalciferols; D008903:Minerals; D010758:Phosphorus; D015650:24,25-Dihydroxyvitamin D 3; D002117:Calcitriol; D002118:Calcium